ViewRay, Inc. (NASDAQ:VRAY)’s share price was up 2.8% on Monday . The stock traded as high as $5.83 and last traded at $5.92. Approximately 314,317 shares were traded during trading, a decline of 9% from the average daily volume of 344,157 shares. The stock had previously closed at $5.76.

A number of research firms have recently issued reports on VRAY. ValuEngine cut shares of ViewRay from a “hold” rating to a “sell” rating in a research report on Friday, September 22nd. Aegis reaffirmed a “buy” rating and issued a $11.00 target price on shares of ViewRay in a research report on Saturday, July 22nd. Mizuho began coverage on ViewRay in a research report on Wednesday, September 6th. They issued a “buy” rating and a $12.00 target price for the company. Finally, Cantor Fitzgerald began coverage on ViewRay in a research note on Thursday, June 29th. They set an “overweight” rating and a $10.00 price target on the stock. One analyst has rated the stock with a sell rating and five have given a buy rating to the company. ViewRay currently has a consensus rating of “Buy” and a consensus price target of $10.00.

The stock’s market cap is $380.60 million. The stock has a 50-day moving average price of $5.83 and a 200 day moving average price of $5.83.

ViewRay (NASDAQ:VRAY) last announced its quarterly earnings results on Monday, August 7th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by ($0.02). The company had revenue of $0.70 million for the quarter, compared to the consensus estimate of $0.68 million. During the same quarter in the prior year, the company earned ($0.32) EPS. ViewRay’s revenue for the quarter was up 133.3% compared to the same quarter last year. On average, equities analysts predict that ViewRay, Inc. will post ($0.82) earnings per share for the current year.

A number of institutional investors have recently bought and sold shares of VRAY. Vanguard Group Inc. grew its holdings in shares of ViewRay by 67.0% during the 2nd quarter. Vanguard Group Inc. now owns 1,026,880 shares of the company’s stock worth $6,644,000 after acquiring an additional 411,866 shares during the period. FIL Ltd purchased a new position in shares of ViewRay in the 1st quarter valued at approximately $6,348,000. State Street Corp lifted its stake in shares of ViewRay by 631.7% in the 2nd quarter. State Street Corp now owns 395,418 shares of the company’s stock valued at $2,555,000 after purchasing an additional 341,376 shares during the period. Next Century Growth Investors LLC purchased a new position in shares of ViewRay in the 1st quarter valued at approximately $2,987,000. Finally, TIAA CREF Investment Management LLC lifted its stake in shares of ViewRay by 2,447.3% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 286,365 shares of the company’s stock valued at $1,853,000 after purchasing an additional 275,123 shares during the period. 53.67% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/10/04/viewray-inc-vray-trading-up-2-8.html.

About ViewRay

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Receive News & Stock Ratings for ViewRay Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ViewRay Inc. and related stocks with our FREE daily email newsletter.